助手标题  
全文文献 工具书 数字 学术定义 翻译助手 学术趋势 更多
查询帮助
意见反馈
   非鳞癌 在 肿瘤学 分类中 的翻译结果: 查询用时:1.568秒
图标索引 在分类学科中查询
所有学科
肿瘤学
妇产科学
眼科与耳鼻咽喉科
更多类别查询

图标索引 历史查询
 

非鳞癌    
相关语句
  non-squamous
    Patients with extensive mediastinal lymph node metastasis, more node metastasis and non-squamous carcinoma showed significantly higher incidence of brain metastasis than those with limited mediastinal lymph node metastasis, fewer positive mediastinal lymph nodes and squamous carcinoma (P=0.000, P=0.000, P=0.013).
    多个区域纵隔淋巴结转移、多个纵隔淋巴结转移以及非鳞癌患者的脑转移发生率显著高于单区域纵隔淋巴结转移、纵隔淋巴结转移数目较少以及鳞癌患者(P=0.000,P=0.000,P=0.013)。
短句来源
    Conclusion High risk factors of brain metastasis in LANSCLC patients after complete resection of the cancer include non-squamous carcinoma, extensive and more mediastinal lymph node metastasis.
    结论局部晚期NSCLC术后脑转移高危因素有:非鳞癌、纵隔多区域淋巴结转移、纵隔多个淋巴结转移。
短句来源
    In this study, the serum level of squamous cell carcinoma antigen(SCCAg) was measured using IMx system by micropartical enzyme immunoassay(MEIA) method in 105 subjects,including 25 healthy pereons(N1), 20 benign pulmonary disease(BPD), 26 patients with non-squamous cell carcinoma(non-SCC) of lung and 34 patients with squamous cell carcinoma(SCC) of lung.
    本实验采用全自动快速荧光酶分析系统(IMx),用微粒子酶免疫测定法(MEIA)测定了105人血清鳞状细胞癌抗原(SCCAg)水平,其中34例肺鳞癌(SCC),26例肺非鳞癌(NSCC)患者血清SCCAg水平,以20例肺良性疾病和25例健康人为对照组。
短句来源
    The number of the risk factors(blood g roup B and non-squamous )were neg atively related to prog nosis acc ording to multivariate analysis in s tag e Ⅲa NSCLC(the 5-year survival rates:43.5%vs 23.7%vs 4.0%,P<0.001).
    随着预后不良因素(非鳞癌和B型血)的增加,Ⅲa期患者5年生存率相应呈下降的趋势(43.5%vs23.7%vs4.0%,P<0.001)。
短句来源
    There was a significant relationship in both abnormal expressions between non-squamous cell cancer (non-SqCC) and non-smokers, but not between SqCC and smokers.
    两者的异常表达在非鳞癌 (non -SqCC)和非吸烟的肺癌者中明显相关 ,而在肺鳞癌和吸烟者中无相关性。
短句来源
更多       
  non-squamous
    Patients with extensive mediastinal lymph node metastasis, more node metastasis and non-squamous carcinoma showed significantly higher incidence of brain metastasis than those with limited mediastinal lymph node metastasis, fewer positive mediastinal lymph nodes and squamous carcinoma (P=0.000, P=0.000, P=0.013).
    多个区域纵隔淋巴结转移、多个纵隔淋巴结转移以及非鳞癌患者的脑转移发生率显著高于单区域纵隔淋巴结转移、纵隔淋巴结转移数目较少以及鳞癌患者(P=0.000,P=0.000,P=0.013)。
短句来源
    Conclusion High risk factors of brain metastasis in LANSCLC patients after complete resection of the cancer include non-squamous carcinoma, extensive and more mediastinal lymph node metastasis.
    结论局部晚期NSCLC术后脑转移高危因素有:非鳞癌、纵隔多区域淋巴结转移、纵隔多个淋巴结转移。
短句来源
    In this study, the serum level of squamous cell carcinoma antigen(SCCAg) was measured using IMx system by micropartical enzyme immunoassay(MEIA) method in 105 subjects,including 25 healthy pereons(N1), 20 benign pulmonary disease(BPD), 26 patients with non-squamous cell carcinoma(non-SCC) of lung and 34 patients with squamous cell carcinoma(SCC) of lung.
    本实验采用全自动快速荧光酶分析系统(IMx),用微粒子酶免疫测定法(MEIA)测定了105人血清鳞状细胞癌抗原(SCCAg)水平,其中34例肺鳞癌(SCC),26例肺非鳞癌(NSCC)患者血清SCCAg水平,以20例肺良性疾病和25例健康人为对照组。
短句来源
    The number of the risk factors(blood g roup B and non-squamous )were neg atively related to prog nosis acc ording to multivariate analysis in s tag e Ⅲa NSCLC(the 5-year survival rates:43.5%vs 23.7%vs 4.0%,P<0.001).
    随着预后不良因素(非鳞癌和B型血)的增加,Ⅲa期患者5年生存率相应呈下降的趋势(43.5%vs23.7%vs4.0%,P<0.001)。
短句来源
    There was a significant relationship in both abnormal expressions between non-squamous cell cancer (non-SqCC) and non-smokers, but not between SqCC and smokers.
    两者的异常表达在非鳞癌 (non -SqCC)和非吸烟的肺癌者中明显相关 ,而在肺鳞癌和吸烟者中无相关性。
短句来源
更多       
  non-squamous cell cancer
    There was a significant relationship in both abnormal expressions between non-squamous cell cancer (non-SqCC) and non-smokers, but not between SqCC and smokers.
    两者的异常表达在非鳞癌 (non -SqCC)和非吸烟的肺癌者中明显相关 ,而在肺鳞癌和吸烟者中无相关性。
短句来源
查询“非鳞癌”译词为用户自定义的双语例句

    我想查看译文中含有:的双语例句
例句
为了更好的帮助您理解掌握查询词或其译词在地道英语中的实际用法,我们为您准备了出自英文原文的大量英语例句,供您参考。
  non-squamous
The percentage of lymphocytes in the differential was greatest in those with non-squamous cancer histology.
      
We reviewed the MR images and pathologic findings of five cases of primary vaginal neoplasms of non-squamous origin.
      
Non-squamous epithelia showed lack of filaggrin expression.
      
FDG PET and PET/CT for the detection of the primary tumour in patients with cervical non-squamous cell carcinoma metastasis of a
      
In patients with a neck metastasis from an unknown primary with non-squamous cell cancer (non-SCC) histology, the primary is often located outside the head and neck area.
      
更多          
  non-squamous cell carcinoma
FDG PET and PET/CT for the detection of the primary tumour in patients with cervical non-squamous cell carcinoma metastasis of a
      
In an on-going Phase II evaluation, dianhydrogalactitol (NSC 132313) was administered intravenously to 28 patients with advanced or recurrent non-squamous cell carcinoma of the cervix.
      
Histologic cell types were grouped into squamous cell carcinoma and non-squamous cell carcinoma, and differentiation into well, moderate and poor.
      
  non-squamous
The percentage of lymphocytes in the differential was greatest in those with non-squamous cancer histology.
      
We reviewed the MR images and pathologic findings of five cases of primary vaginal neoplasms of non-squamous origin.
      
Non-squamous epithelia showed lack of filaggrin expression.
      
FDG PET and PET/CT for the detection of the primary tumour in patients with cervical non-squamous cell carcinoma metastasis of a
      
In patients with a neck metastasis from an unknown primary with non-squamous cell cancer (non-SCC) histology, the primary is often located outside the head and neck area.
      
更多          
  non-squamous cell cancer
In patients with a neck metastasis from an unknown primary with non-squamous cell cancer (non-SCC) histology, the primary is often located outside the head and neck area.
      
  其他


In this study, the serum level of squamous cell carcinoma antigen(SCCAg) was measured using IMx system by micropartical enzyme immunoassay(MEIA) method in 105 subjects,including 25 healthy pereons(N1), 20 benign pulmonary disease(BPD), 26 patients with non-squamous cell carcinoma(non-SCC) of lung and 34 patients with squamous cell carcinoma(SCC) of lung. The normal value of serum SCCAg level was 2μg/L in this experiment. The serum SCCAg level in patients with lung SCC (3. 660±3. 027μg/L) was much higher than...

In this study, the serum level of squamous cell carcinoma antigen(SCCAg) was measured using IMx system by micropartical enzyme immunoassay(MEIA) method in 105 subjects,including 25 healthy pereons(N1), 20 benign pulmonary disease(BPD), 26 patients with non-squamous cell carcinoma(non-SCC) of lung and 34 patients with squamous cell carcinoma(SCC) of lung. The normal value of serum SCCAg level was 2μg/L in this experiment. The serum SCCAg level in patients with lung SCC (3. 660±3. 027μg/L) was much higher than that in patients with lung non-SCC(1.724±1.406μg/L P<0. 01), BPD(1.046±0. 485 μg/L, P<0.01) and N1 group (0. 755±0. 495μg/L P<0. 01). Elevated levels of SCCAg were observed in 16(47. 1%) of 34 patients with lung SCC, in 2(7.7%) of 26 patients with non-SCC and in none of the 20 BPD and N1 group. The results suggest that serum SCCAg level is a relatively specific marker for lung SCC. Its level is of important significance for diagnosis and differential diagnosis for lung SCC, especially for differentiating SCC patients from non-SCC ones.

本实验采用全自动快速荧光酶分析系统(IMx),用微粒子酶免疫测定法(MEIA)测定了105人血清鳞状细胞癌抗原(SCCAg)水平,其中34例肺鳞癌(SCC),26例肺非鳞癌(NSCC)患者血清SCCAg水平,以20例肺良性疾病和25例健康人为对照组。取2μg/L为正常值上限,超过此值为阳性,结果显示:血清SCCAg水平在肺SCC组(3.660±3.027μg/L)明显高于正常对照组(0.755±0.495μg/L)、肺良性疾病组(1.046±0.485μg/L)和肺NSCC组(1.724±1.406μg/L)(P<0.01)。两对照组中,无1例大于2μg/L,26例肺NSCC组中,2例(7.7%)阳性,而34例肺SCC组中,16例(47.1%)阳性。结果表明,血清SCCAg水平对肺鳞癌有较高的特异性,对肺鳞癌的诊断,鉴别诊断,特别是在肺癌的组织学分型中,区别肺鳞癌和肺非鳞癌有重要意义。

The results of histological observation on mediastinal nodes resected in 56 cases of non-small cell lung cancer were analysed. Enlarged mediastinal nodes with diameter greater than 1. 0cm presented in 52 cases (92.9 % ), including 11 cases of presumed N, disease and 41 cases of presumed N2 diseases. But only 19 true N2 diseases were confirmed by pathological examination, including 3 N1 disease and 16 N2 disease. One true N1 disease was found in 4 presumed N0 disease. Presumed N2disease was given to in all...

The results of histological observation on mediastinal nodes resected in 56 cases of non-small cell lung cancer were analysed. Enlarged mediastinal nodes with diameter greater than 1. 0cm presented in 52 cases (92.9 % ), including 11 cases of presumed N, disease and 41 cases of presumed N2 diseases. But only 19 true N2 diseases were confirmed by pathological examination, including 3 N1 disease and 16 N2 disease. One true N1 disease was found in 4 presumed N0 disease. Presumed N2disease was given to in all 16 cases of squamous carcinoma, however only 2 were true(11.1 % ). On the other hand 14 true N2 disease (56% ) presented in 25 cases of adenocarcinoma with presumed N2 disease (P<0.01). Hence, it is impossible to assess N disease and stage of lung cancer preoperatively by the size of node, especially in case of squamous carcinoma. Thoractomy is advisable in cases of enlarged mediastinal nodes when the histological evidence of mediastinal involvement is not available.

报告56例非小细胞肺癌(NSCLC)手术摘除的纵隔淋巴结标本的直接观察结果。发生淋巴结肿大(直径≥1.0cm)假定为N病变52例(92.9%)。其中假定N111例,N241例。经病理学检查确定为N病变19例,包括N13例,N216例。假定为N0病变4例,其中1例为真正N1病变。鳞癌患者普遍为假定的N2病变,但真正N病变发生率低(2/16例,11.1%),和非鳞癌患者(14/25例,56%)对比,差异有非常显著性(P<0.01)。因此,仅根据纵隔淋巴结大小不能可靠地评估N病变和术前分期,特别是鳞癌。在发生纵隔淋巴结肿大,但未取得转移病变的组织学依据时,应争取开胸探查手术治疗。

Objective:Prognostic factors were evaluated in 192 non small cell lung carcinoma (NSCLC)patients who had received radical radiotherapy with or without chemotherapy.Methods:The fractionated schedules in radiotherapy were conventional fraction(CF),hyperfractionation(HF),and accelerated hyperfractionation(HART).Univariate analysis and COX model were used.Results:Squamous cell cancer,early stage,nonconventional fraction,good immediate radiation responses were favourable prognostic factors.The 1 and 2 year survival...

Objective:Prognostic factors were evaluated in 192 non small cell lung carcinoma (NSCLC)patients who had received radical radiotherapy with or without chemotherapy.Methods:The fractionated schedules in radiotherapy were conventional fraction(CF),hyperfractionation(HF),and accelerated hyperfractionation(HART).Univariate analysis and COX model were used.Results:Squamous cell cancer,early stage,nonconventional fraction,good immediate radiation responses were favourable prognostic factors.The 1 and 2 year survival rates were as follows:squamous 80.3%,43.6%,nonsquamous 62.4%,32.1%( P =0.005);Ⅰ+Ⅱ stage 82.4%,64.2%,Ⅲ a 78.2%, 42.9%,Ⅲ b 63.8%,26.8%( P =0.003);CF 69.3%,29.0%,HF 76.4%,41.4%,HART 78.2%,54.0%( P =0.011);CR 81.1%,57.4%,PR 80.1%,42.2%,NR+PD 52.5%,18.3%( P <0.001).Conclusions:Histology type, stage ,radiotherapy methods,immediate radiation responses were independent prognostic factors.

对192例非小细胞肺癌(NSCLC)接受以放射治疗为主的非手术根治性治疗后,研究有影响的预后因子。方法采用单因素分析和COX多因素模型分析。结果病期早者,鳞癌患者,采用非常规分割放疗者,放疗结束时即期疗效好者,其生存预后好。在各分组中,一、二年生存率为:鳞癌患者80.3%,43.6%,非鳞癌患者62.4%,32.1%(P=0.005);Ⅰ+Ⅱ期82.4%,64.2%,Ⅲa78.2%,42.9%,Ⅲb63.8%,26.8%(P=0.003);常规放疗69.3%,29.0%,超分割76.4%,41.4%,加速超分割78.2%,54.0%(P=0.011);即期疗效完缓解者81.1%,57.4%,部分缓解者80.1%,42.2%,无变化或进展者52.5%,18.3%(P<0.001)。结论病理类型,病期,放射治疗方法,放疗结束时即期疗效为独立的预后因子。

 
<< 更多相关文摘    
图标索引 相关查询

 


 
CNKI小工具
在英文学术搜索中查有关非鳞癌的内容
在知识搜索中查有关非鳞癌的内容
在数字搜索中查有关非鳞癌的内容
在概念知识元中查有关非鳞癌的内容
在学术趋势中查有关非鳞癌的内容
 
 

CNKI主页设CNKI翻译助手为主页 | 收藏CNKI翻译助手 | 广告服务 | 英文学术搜索
版权图标  2008 CNKI-中国知网
京ICP证040431号 互联网出版许可证 新出网证(京)字008号
北京市公安局海淀分局 备案号:110 1081725
版权图标 2008中国知网(cnki) 中国学术期刊(光盘版)电子杂志社